Hyperfractionated radiation therapy for oropharyngeal carcinoma in a Japanese population

Japanese Journal of Clinical Oncology

Volumn 34, Issue 6, 2004, Pages 312-315

  Niibe, Yuzuru ^a,b   Karasawa, Katsuyuki ^a   Mitsuhashi, Toshio ^a   Miyashita, Hisao ^a   Tanaka, Yoshiaki ^c  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperfractionated radiation therapy; Japanese population; Oropharyngeal carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; JAPAN; LYMPH NODE METASTASIS; MALE; OROPHARYNX CARCINOMA; PHARYNX DISEASE; POPULATION RESEARCH; RADIATION DOSE FRACTIONATION; RISK BENEFIT ANALYSIS; SKIN TOXICITY; SURVIVAL RATE; TREATMENT OUTCOME; ASIAN; CARCINOMA; EVALUATION; MIDDLE AGED; OROPHARYNX TUMOR; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY; SURVIVAL RATE;

EID: 6044228297     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh049     Document Type: Article

References (11)

1. Horiot JC, Fur RL, N'Guyen T, Chenal C, Schraub S, Alfonsi S, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
2. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiation therapy for head and neck squamous cell carcinoma: First report of RTOG9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
3. WHO Handbook For Reporting Results of Cancer Treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48: 1979.
4. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [Editorial]. Int J Radiat Oncol Biol Phys 1995;31:1341-6.
5. International Union Against Cancer. Pharynx. In Sobin LH, Wittekind CH, editors. TNM Classification of Malignant Tumours, 5th edn. New York: Wiley-Liss, Inc. 1997; pp. 25-32.
6. Sakata K, Aakanuma A, Aoki Y, Nakagawa K, Karasawa K, Iio M. Radiation therapy of carcinoma of the oropharynx. Radiat Med 1989;7:189-92.
7. Tayler JM, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990;17:95-102.
8. Flyes A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-9.
9. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-88.
10. Nishimura Y, Nagata Y, Okajima K, Mitsumori M, Hiraoka M, Masunaga S, et al. Radiation therapy for T1-2 glottic carcinoma; Impact of overall treatment time on local control. Radiother Oncol 1996;40:225-32.
11. Karasawa K, Okawa T, Kita-Okawa M, Fukuhara N, Kaneyasu Y, Takemoto M, et al. Twice-a-day fractionated radiotherapy with chemotherapy for locally advanced head and neck cancer. Radiother Oncol 1997; 43:S115.